Elizabeth J. Shpall

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

Elizabeth J. Shpall
Apr 11, 2025, 15:47 | Blog
Major microbiome disruption and Toxicities Following Idecabtagene Vicleucel in Multiple Myeloma patients
Muzaffar Qazilbash, Professor of Medicine at UT- MD Anderson Cancer Center, shared a post on…
Jan 26, 2025, 14:04 | Opinion
5 Articles in Immunotherapy suggested by Wafik El-Deiry
Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at…
Jan 3, 2025, 13:22 | Science
Myeloma Paper of the Day, January 3rd, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Study of standard-risk myeloma…
Dec 24, 2024, 14:25 | Opinion
Portia Smallbone: HCT in patients with MF and splanchnic vein thrombosis
Portia Smallbone , Hematologist and Transplant Physician at MD Anderson Cancer Center, shared a post…
Nov 2, 2024, 14:46 | Insight
Myeloma Paper of the Day, November 2nd, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Study of optimal infused CD34+…
Oct 26, 2024, 09:18 | Insight
Myeloma Paper of the Day, October 26th, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: Study of real-world outcomes of upfront ASCT…
Aug 15, 2024, 07:54 | Insight
Preclinical study by MD Anderson Cancer Center represents the first use of IL-21 NK cells in glioblastoma
NK cells expressing interleukin-21 show promising antitumor activity in glioblastoma cells Natural killer (NK) cells…
Jul 20, 2024, 12:53 | Insight
Cyclophosphamide–Based GVHD Prophylaxis Reduces Outcome Disparity in Transplants
CIBMTR shared a post on X about a recent paper.  . Authors: Brian C. Shaffer,…
Jul 5, 2024, 16:30 | Insight
CAR NK cells with CD28 costimulation improved cell persistence and antitumor activity
Adding CD28 costimulation to cord blood-derived chimeric antigen receptor (CAR) natural killer (NK) cells targeting…
Jun 23, 2024, 05:10 | Insight
Yan Leyfman: Pioneering work that is enhancing NK CAR efficacy
Yan Leyfman, Internal Medicine and Clinical Researcher at Icahn School of Medicine at Mount Sinai,…
Jun 10, 2024, 15:38 | Insight
Myeloma Paper of the Day, June 10th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: MD Anderson Cancer Center study of…
May 18, 2024, 15:37 | Insight
Myeloma Paper of the Day, May 18th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Myeloma patients with long remission post-ASCT…
All: 12 Posts: 1 - 100
Special Coverage